Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancer Biology & Therapy|September 26, 2003
Restoring p53-dependent tumor suppressionWenge Wang, Farzan Rastinejad, Wafik S El-DeiryMolecular and Cellular Biology|March 4, 2003
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 bindingWenge Wang, Rishu Takimoto, Farzan Rastinejad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Structural and functional basis for therapeutic modulation of p53 signalingEmily A Bassett, Wenge Wang, Farzan Rastinejad, et al.Cancer Biology & Therapy|August 15, 2002
The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 proteinRishu Takimoto, Wenge Wang, David T Dicker, et al.Cancer Research|November 13, 2003
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapyJean S Beebe, Jitesh P Jani, Elisabeth Knauth, et al.Pageof 1